D-0313-2025 Class II Terminated

Recalled by ASEGUA THERAPEUTICS LLC — Foster City, CA

FDA drug recall D-0313-2025 was initiated by ASEGUA THERAPEUTICS LLC on Mar 7, 2025 and is designated Class II. Reason for recall: Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton. The recall status is terminated (terminated Sep 29, 2026). Affected quantity: 18,541 cartons.

Recall details

Product Type
Drugs
Report Date
Apr 16, 2025
Initiation Date
Mar 7, 2025
Termination Date
Sep 29, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18,541 cartons.

Product description

Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1

Reason for recall

Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

Distribution pattern

US Nationwide

Code information

Lot# 24ASV002UA, Exp Date: 6/30/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0313-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0313-2025. Report a data issue: hello@regdatalab.com.